Orbital meningioma post craniospinal radiation for haematological malignancy: case series
Shiran Madgar-Golfor, Mary Henry, Mark Dexter, Simon Taylor, Krishna Tumuluri Eye
· Springer Nature
· 2026-11-18
· DOI: 10.1038/s41433-026-05054-3
Аннотация
Eye, Published online: 18 November 2026; doi:10.1038/s41433-026-05054-3 Orbital meningioma post craniospinal radiation for haematological malignancy: case series
Shiran Madgar-Golfor, Mary Henry, Mark Dexter, Simon Taylor, Krishna Tumuluri. Orbital meningioma post craniospinal radiation for haematological malignancy: case series. // Eye. – 2026. – DOI: 10.1038/s41433-026-05054-3. – URL: https://www.nature.com/articles/s41433-026-05054-3
Shiran Madgar-Golfor, Mary Henry, Mark Dexter, Simon Taylor, & Krishna Tumuluri (2026). Orbital meningioma post craniospinal radiation for haematological malignancy: case series. Eye. https://doi.org/10.1038/s41433-026-05054-3
Shiran Madgar-Golfor, et al. “Orbital meningioma post craniospinal radiation for haematological malignancy: case series.” Eye, 2026. doi:10.1038/s41433-026-05054-3.
@article{MadgarGolfor2026,
title = {Orbital meningioma post craniospinal radiation for haematological malignancy: case series},
author = {Madgar-Golfor, Shiran and Henry, Mary and Dexter, Mark and Taylor, Simon and Tumuluri, Krishna},
journal = {Eye},
year = {2026},
doi = {10.1038/s41433-026-05054-3},
url = {https://www.nature.com/articles/s41433-026-05054-3}
}
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05030-x Comment on: ‘Association of accelerometer-monitored physical activity with incident cataract: epidemiological and genetic evidence’
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05032-9 NAION during incretin-based therapy: an optic nerve head still adapted to hypertension
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05016-9 Comparing refractive errors in CACNA1F and CABP4 -associated disease in a UK cohort
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05018-7 Comment on: ‘Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease’